Global Anti-Snoring Devices and Snoring Surgery Market by Product Type (Anti-Snoring Devices, Snoring Surgery), by Device Type (Mandibular Advancement Devices (MADs), Continuous Positive Airway Pressure (CPAP), Nasal Dilators, Chin Straps, Tongue Stabilizing Devices (TSD)), by Surgical Procedure Type (Uvulopalatopharyngoplasty (UPPP), Genioglossus Advancement Surgery, Laser-Assisted Uvulopalatoplasty (LAUP), Somnoplasty), by End-Use Industry (Hospitals, Sleep Centers, Homecare); Insights & Forecast (2024 ? 2030)

As per Intent Market Research, the Anti-Snoring Devices and Snoring Surgery Market was valued at USD 2.1 Billion in 2024-e and will surpass USD 3.8 Billion by 2030; growing at a CAGR of 10.3% during 2025 - 2030.

 The anti-snoring devices and snoring surgery market has experienced significant growth in recent years, driven by the increasing awareness of the health risks associated with snoring and sleep apnea. Snoring not only affects the quality of sleep but also leads to other health complications such as cardiovascular issues, fatigue, and decreased cognitive function. As a result, both non-invasive devices and surgical procedures have gained popularity as effective solutions. This market is expanding due to the rising prevalence of sleep-related disorders and the growing focus on enhancing sleep quality, with innovations in both devices and surgeries providing more personalized and effective treatment options.

Mandibular Advancement Devices (MADs) Is Largest Device Type Owing to Effectiveness and Comfort

The Mandibular Advancement Devices (MADs) segment is the largest device type in the market, driven by their effectiveness in treating snoring and obstructive sleep apnea. MADs work by repositioning the lower jaw slightly forward, which helps to keep the airway open during sleep and reduce the vibrations that cause snoring.

The popularity of MADs is attributed to their non-invasive nature, ease of use, and ability to provide immediate relief for snoring sufferers. Compared to other snoring devices like CPAP and nasal dilators, MADs are more comfortable and have a higher adoption rate due to their portability and minimal disruption to sleep. This makes them the go-to solution for many patients who seek simple, convenient, and effective treatments for snoring.

Uvulopalatopharyngoplasty (UPPP) Is Most Common Surgical Procedure Owing to High Success Rate

Uvulopalatopharyngoplasty (UPPP) is the most common surgical procedure in the anti-snoring surgery market, mainly due to its high success rate and effectiveness in treating snoring and sleep apnea. UPPP involves the removal of excess tissue from the throat, including the uvula and parts of the soft palate, to widen the airway and reduce snoring.

This procedure is often recommended for patients who have not responded well to non-invasive treatments and have moderate to severe snoring or obstructive sleep apnea. The high success rate of UPPP in alleviating symptoms and improving sleep quality, along with advancements in surgical techniques, continues to make it the most widely performed procedure for snoring and sleep apnea treatment.

Hospitals Segment Is Largest End-Use Industry Due to Complex Cases and Surgical Treatment Needs

The hospitals segment is the largest end-use industry for anti-snoring devices and snoring surgery, driven by the need for medical expertise in managing complex cases of snoring and sleep apnea. Hospitals provide a range of treatment options, from non-invasive devices to advanced surgical procedures, for patients who require professional care and follow-up.

Hospitals offer a comprehensive approach to treating snoring, where patients can undergo diagnostic testing to determine the underlying cause of their condition and receive personalized treatment plans. As the prevalence of sleep apnea and related disorders increases, hospitals are playing a critical role in addressing more severe cases of snoring and sleep-related breathing issues, making them the largest end-use segment.

North America Is Largest Region Owing to High Awareness and Advanced Healthcare Infrastructure

North America is the largest regional market for anti-snoring devices and snoring surgery, owing to the high awareness of sleep disorders, advanced healthcare infrastructure, and the widespread adoption of both surgical and non-surgical treatments. The United States, in particular, has a large population affected by snoring and obstructive sleep apnea, leading to a strong demand for both medical devices and surgical interventions.

The region benefits from a well-established healthcare system that promotes early diagnosis and effective treatment options, as well as a high level of consumer awareness regarding the importance of sleep health. With advancements in medical technology and growing access to sleep centers and specialized healthcare professionals, North America continues to dominate the market for anti-snoring solutions.

Competitive Landscape and Key Players

The anti-snoring devices and snoring surgery market is highly competitive, with key players such as Philips Healthcare, ResMed, SomnoMed, and SnoreRx offering a wide range of products and solutions. These companies focus on innovation, providing consumers with increasingly effective and comfortable devices, as well as offering advanced surgical options through healthcare providers.

In the surgical segment, companies like Medtronic and Olympus are leading the market by offering cutting-edge equipment and techniques for performing snoring surgeries. The competitive landscape is characterized by a mix of established players in the healthcare and medical device sectors, alongside smaller specialized companies focused on innovative snoring treatments. As the market evolves, companies are increasingly focused on developing personalized, minimally invasive treatments to cater to the diverse needs of snoring patients, ensuring continued growth and competition in this sector.

Recent Developments:

• ResMed announced the launch of a new CPAP machine designed with advanced features for comfortable snoring treatment and sleep apnea management.
• SomnoMed received approval for a new mandibular advancement device designed for patients with moderate to severe obstructive sleep apnea, improving snoring and overall sleep quality.
• Fisher & Paykel Healthcare unveiled its new snoring treatment device, incorporating advanced humidification and airflow control for better user comfort.
• Medtronic launched a new somnoplasty device for the treatment of snoring and sleep apnea, offering minimally invasive surgical options.
• Mayo Clinic conducted a study highlighting the effectiveness of snoring surgery over long-term use of anti-snoring devices, leading to a rise in surgical consultations.

List of Leading Companies:

• Philips Healthcare
• ResMed
• Fisher & Paykel Healthcare
• SomnoMed
• ApneaMed
• ProSomnus Sleep Technologies
• Orthofix Medical Inc.
• Mayo Clinic
• Medtronic
• SleepMed
• Mandibular Advancement Devices (MAD)
• Entellus Medical
• The American Academy of Sleep Medicine
• GlaxoSmithKline (GSK)
• BMC Medical Co. Ltd.

Report Scope: